Cargando…

Defining the Role of Immunotherapy in the Curative Treatment of Locoregionally Advanced Head and Neck Cancer: Promises, Challenges, and Opportunities

Recent advancements in the development of immunotherapies have raised the hope for patients with locally-advanced HNSCC (LA-HNSCC) to achieve improved oncologic outcomes without the heavy burden of treatment-related morbidity. While there are several ongoing late phase clinical trials that seek to d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saddawi-Konefka, Robert, Simon, Aaron B., Sumner, Whitney, Sharabi, Andrew, Mell, Loren K., Cohen, Ezra E. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490924/ https://www.ncbi.nlm.nih.gov/pubmed/34621678 http://dx.doi.org/10.3389/fonc.2021.738626

Ejemplares similares

Treatment Considerations for Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
por: Kim, Sangwoo S., et al.
Publicado: (2023)

Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer
por: Wang, Zhiyong, et al.
Publicado: (2021)

Predicting 90-Day Mortality in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma after Curative Surgery
por: Qin, Lei, et al.
Publicado: (2018)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Chronic Viral Infection and Primary Central Nervous System Malignancy
por: Saddawi-Konefka, Robert, et al.
Publicado: (2010)

The role of p16 as a biomarker in nonoropharyngeal head and neck cancer
por: Vitzthum, Lucas K., et al.
Publicado: (2018)

Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response
por: Guram, Kripa, et al.
Publicado: (2018)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Assessment and topographic characterization of locoregional recurrences in head and neck tumours
por: Ferreira, Brigida Costa, et al.
Publicado: (2015)

Doing More With Written Feedback: Improving Learner Satisfaction and Reflection With the LEAF (Learner-Engaged Analysis of Feedback) Method
por: Saddawi-Konefka, Daniel, et al.
Publicado: (2021)

Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study
por: Kubota, Akira, et al.
Publicado: (2018)

Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy
por: Faraji, Farhoud, et al.
Publicado: (2023)

Adult Head and Neck Rhabdomyosarcoma: Management, Outcomes, and the Effect of Intensity Modulated Radiation Therapy on Locoregional Control
por: Hahn, Ezra, et al.
Publicado: (2022)

Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022)

Cutaneous Angiosarcoma of Head and Neck: A New Predictive Score for Locoregional Metastasis()()
por: Gründahl, J.E.H., et al.
Publicado: (2015)

Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies
por: Gao, Jing, et al.
Publicado: (2019)

End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma
por: Sumner, Whitney, et al.
Publicado: (2021)

Incidence of Long-Term Esophageal Dilation With Various Treatment Approaches in the Older Head and Neck Cancer Population
por: Green, Garrett, et al.
Publicado: (2018)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
por: Liu, Hsiao-Tien, et al.
Publicado: (2020)

Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
por: Bazeed, Alaa Y., et al.
Publicado: (2022)

Persistent Post-radiotherapy Pain and Locoregional Recurrence in Head and Neck Cancer-Is There a Hidden Link?
por: Srivastava, Preety, et al.
Publicado: (2015)

Treatment intensity in locoregionally advanced head and neck cancer: recent investigation leads to new questions
por: Bonner, James A., et al.
Publicado: (2019)

Neoadjuvant immunotherapy of locoregionally advanced solid tumors
por: Tarhini, Ahmad A, et al.
Publicado: (2022)

Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers
por: Zhou, Jade Z., et al.
Publicado: (2021)

Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy
por: Raj, Roma, et al.
Publicado: (2023)

Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer
por: Bhide, S A, et al.
Publicado: (2008)

Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer
por: Bruixola, Gema, et al.
Publicado: (2018)

Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice
por: Szturz, Petr, et al.
Publicado: (2019)

Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes
por: Chang, Jer-Hwa, et al.
Publicado: (2017)

The Impact of Locoregional Treatment on Response to Nivolumab in Advanced Platinum Refractory Head and Neck Cancer: The Need Trial
por: Botticelli, Andrea, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Defining the target for radiotherapy of head and neck cancer
por: Nuyts, S.
Publicado: (2007)

Mental Health Questions on State Medical License Applications and Evaluation of Updates
por: Douglas, Rachel N., et al.
Publicado: (2023)

Window of opportunity trials in head and neck cancer
por: Farlow, Janice L., et al.
Publicado: (2019)

Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection
por: Leng, Kai-Ming, et al.
Publicado: (2017)

Evaluating predictive factors for toxicities experienced by head & neck cancer patients undergoing radiotherapy
por: Ray, Xenia, et al.
Publicado: (2021)

The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers
por: Saidian, Ava, et al.
Publicado: (2022)

Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma—The French Experience
por: Machavoine, Roxane, et al.
Publicado: (2022)

Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma
por: Chen, Tien-Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5rila04vscjai63n4bpfc6l319